Taking phosphate binders may lower the risk of osteoporotic fractures in patients initiating dialysis. Oral phosphate binders may decrease the risk for osteoporotic fracture in patients starting ...

Nicotinamide and Lanthanum Carbonate and Changes in Serum Phosphate and Fibroblast Growth Factor-23 in Patients With CKD: The COMBINE Trial Inclusion criteria for this randomized, double-blind, ...

In a study, hemoglobin values did not differ meaningfully among daprodustat users, whether or not they also took one or more phosphate binders. Phosphate binders do not appear to substantially affect ...

Please provide your email address to receive an email when new articles are posted on . The Kidney Patient Act would delay placement of oral phosphate binders into ...

ISTANBUL, Turkey — The investigational drug PA21 controls hyperphosphatemia over the long term and has a lower pill burden than sevelamer carbonate, according to a phase 3 study. The cardiovascular ...

Given the suboptimal outcomes with existing therapies to manage chronic kidney disease patients on dialysis, there is a substantial unmet need that additional treatment options could potentially ...

Trial investigated lanthanum carbonate, which has been used worldwide to treat hyperphosphatemia and has been reported to delay vascular calcification. Using a non-calcium instead of a calcium-based ...

Please provide your email address to receive an email when new articles are posted on . Patients with chronic kidney disease on maintenance dialysis experienced improved control of hyperphosphatemia ...

Unlike phosphate binders, tenapanor decreases paracellular phosphate absorption in the intestine. Tenapanor may reduce the number of phosphate binder pills patients on hemodialysis (HD) take daily to ...

LOS ALTOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...

Online survey findings showed significant challenges with compliance to phosphate binder therapy. Among 200 dialysis patients, 37% were non-compliant with their phosphate binders compared with 12% to ...